Patent · US Active

Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists

US9029360B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Dirk Gottschling · Mittelbiberach, DE
Heiner Ebel · Biberach an der Riß, DE
Doris Riether · Biberach an der Riß, DE
Bernd Wellenzohn · Friedrichshafen, DE

Key dates

Filing date	Mar 27, 2013
Grant date	May 12, 2015
Priority date	—
Expiry date	Jun 29, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel pyrazolopyrimidines and their use as metabotropic glutamate 5 receptor antagonists (mGlu5 receptor antagonists), pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of mGlu5 receptor mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.